EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dietary Carnosine Supplementation in Healthy Human Volunteers: A Safety, Tolerability, Plasma and Brain Concentration Study

Ali N Ali iD, Li Su, Jillian Newton iD, Amy K Grayson iD, David Taggart iD, Simon M Bell iD, Sheharyar Baig, Iain Gardner, Barbora de Courten iD, Arshad Majid

Nutrients · 2025

DOI: 10.3390/nu17132130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Ali N Ali und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2TN, UK. Hauptthemen laut MEDLINE: Carnosine, Dietary Supplements, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hestia (Czechia), Hestia Investments, Clinical Research Facility.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Carnosine is a multimodal pleotropic endogenous molecule that exhibits properties that make it a compelling therapeutic agent for further evaluation in a number of diseases. However, little data currently exists on its pharmacokinetic profile, maximum tolerated doses, side effects and whether oral administration can lead to elevated brain concentrations.

Method

To investigate this, sixteen healthy volunteers underwent a single dose-escalation study of oral carnosine to establish safety, tolerability, and pharmacokinetics. A subset (n = 5) underwent Proton Magnetic Resonance Imaging (MRI) spectroscopy to evaluate the effect of oral dosing on brain carnosine concentrations, and another subset (n = 4) completed a long-term (4-week) dosing study.

Results

Oral carnosine was safe and well tolerated up to a dose of 10 g. At doses of 15 g, the frequency of adverse events became unacceptably high, with 77% of participants experiencing side effects, most commonly headache (43.5%), nausea (21.7%) and paraesthesia (21.7%). While pharmacokinetic profiles varied between individuals, peak plasma concentrations occurred within the first hour of dosing. Little circulating carnosine was detectable beyond 4 h. Brain carnosine concentration increased at 1 h post-dose but reverted to baseline values by 5 h. Long-term dosing at 5 g twice daily did not result in any adverse events.

Conclusions

Our data will inform dosing interventions in future clinical trials of this exciting agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarnosineDietary SupplementsBrainHumansMaleAdultFemaleHealthy VolunteersYoung AdultAdministration, OralMiddle AgedDose-Response Relationship, Drug

Stichwörter der Autor:innen

brain concentrationcarnosinehistidinepharmacokineticssafety and tolerability

Substanzen

Carnosine

Autor:innen und Institutionen

  • Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2TN, UK.
  • Combined Community and Acute Care Group, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2JF, UK.
  • Department of Psychiatry, University of Cambridge, Cambridge CB2 1TN, UK.
  • Biomolecular Science Research Centre, Sheffield Hallam University, Sheffield S1 1WB, UK.
  • Glycyx MOR, Inc., San Francisco, CA 94121, USA.
  • Translational DMPK Science, Certara UK Limited, Sheffield S1 2BJ, UK.

ORCID-Profile: Ali N Ali, Jillian Newton, Amy K Grayson, David Taggart, Simon M Bell, Barbora de Courten

Förderung

  • Hestia (Czechia)
  • Hestia Investments
  • Clinical Research Facility
  • Sheffield Biomedical Research Centre, Sheffield, UK

Zitieren

APA

Ali, A. N., Su, L., Newton, J., Grayson, A. K., Taggart, D., Bell, S. M., Baig, S., Gardner, I., de Courten, B., & Majid, A. (2025). Dietary Carnosine Supplementation in Healthy Human Volunteers: A Safety, Tolerability, Plasma and Brain Concentration Study. Nutrients. https://doi.org/10.3390/nu17132130

Vancouver

Ali AN, Su L, Newton J, Grayson AK, Taggart D, Bell SM, et al. Dietary Carnosine Supplementation in Healthy Human Volunteers: A Safety, Tolerability, Plasma and Brain Concentration Study. Nutrients. 2025. doi:10.3390/nu17132130

BibTeX
@article{Ali2025,
  author = {Ali, Ali N and Su, Li and Newton, Jillian and Grayson, Amy K and Taggart, David and Bell, Simon M and Baig, Sheharyar and Gardner, Iain and de Courten, Barbora and Majid, Arshad},
  title = {Dietary Carnosine Supplementation in Healthy Human Volunteers: A Safety, Tolerability, Plasma and Brain Concentration Study},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17132130}
}
Kostenlos starten →